Champions Oncology Names Angela Davies, M.D., Chief Medical Officer DigitalJournal.com Previously, she was Chief Medical Officer of OSI Pharmaceuticals where she led the clinical development program for Tarceva® (erlotinib), as well as other...
SANTA CLARA, Calif. — A new mobile game app designed by CyberDoctor showed improvements in medication adherence, diet and exercise in diabetes patients, according to a study. The company said that breakthrough clinical trial results for the game, called PatientPartner," documented for the first time the effectiveness of a story-driven game in changing health behavior and biomarkers. The study was conducted among 100 nonadherence patients at Hershey, Pa.-based Pinnacle Health Systems and presented at the Health2.0 Conference Wednesday in Santa Clara, Calif. According to the study, medication adherence among patients using the game increased from 58% to 95%, equivalent to three additional days of adherence per week. Meanwhile, diet and exercise adherence respectively increased by 24% and 14%, all contributing to a decrease in blood sugar levels from 10.7% to 9.7%.
When it comes to digital resources available to US healthcare consumers, research shows WebMD to be the most popular online tool. Pharma websites, meanwhile, trail every other online health information resource.
Guest Post: How Technology is Driving Communication in Pharma 3BL Media (press release) Meanwhile, their audience, the empowered health consumers, are out there in the digital space, searching for information about their health, their treatment...
How Mobiles Make Clinical Trials Bigger, Faster and More Efficient SelectScience.net (press release) This post-marketing study to assess the medication adherence of patients with diabetes in an emerging market included provisioned smartphones, a...
Within the pharma industry, and indeed all other industries, there is an abundance of talk about how social media should or could be used for business benefit. A quick Google search alone returns almost 200 million results for “social media” and over 6 million if you add the word “pharma” in there too.
Among all this feverish blogging, it is rare that anyone stops to explain exactly what they mean by social media. But surely it’s obvious and we all know what it is, right?
I’m not so sure.
You see, I would observe that there are many companies proclaiming to be avid social media users who are actually not, and even some who think they are not but actually are. Confused? Well , it all depends on exactly how you define social media.
My own view (representing a sample of one, and possibly just one) is that we get rather fixated on ‘channels’ when we talk about social media. For example, “our company has a Twitter account so we use social media”, or “our Facebook page has 1,000 followers so we use social media”. However, these are just online media channels, which are enabled for social engagement, but it’s how you use them that makes them social.
So here is an alternative definition of social media (with apologies to anyone I am inadvertently ripping off as I promise this is just from my head):
“The term ‘social media’ refers to using digital media channel channels to engage in two-way or multi-way conversation with other individuals and therefore have online social interaction.”
OK, so it’s not the most punchy, but it does make you look at who is active in using social media in a different way.
Radius Announces Key Changes to Management Team DigitalJournal.com "John has extensive leadership, strategic, and technical experience at the highest levels of pharmaceutical drug development in multiple therapeutic areas, including osteoporosis.
There is a misconception within marketing that just because people are using a certain technology or going to a certain website that they want marketers to follow them there. The rule seems to be... [[ This is a content summary only.
Pharmaceutical companies should establish a corporate social media policy, attorney John Manthei, with Latham & Watkins LLP in Washington, said Sept. 17.
Speaking during a session on drug product compliance at the Food and Drug Law Institute's Advertising & Promotion Conference, Manthei said the Food and Drug Administration is “incredibly” advanced at using social media, but it hasn't yet said how it will regulate others when it comes to social media.
Manthei said the FDA is required by the Food and Drug Administration Safety and Innovation Act of 2012 (FDASIA) to issue specific guidance on social media by July 9, 2014. However, he said FDA's message in warning letters has been that “current standards apply” when it comes to social media.
Social media is “interactive and the formats are constantly evolving,” Manthei said.
Manthei said companies should establish a “clear corporate social media policy and provide adequate training to employees.”
Additionally, Manthei said that companies should ensure that their internal and promotional labeling review program is “attuned to developing issues in the media space.”
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.